Inlet Private Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,229
Closed -$256K 131
2024
Q3
$256K Hold
2,229
0.07% 119
2024
Q2
$237K Buy
+2,229
New +$224K 0.06% 120
2024
Q1
Sell
-2,059
Closed -$208K 125
2023
Q4
$208K Sell
2,059
-1,200
-37% -$116K 0.06% 115
2023
Q3
$332K Sell
3,259
-50
-2% -$5.08K 0.11% 103
2023
Q2
$334K Hold
3,309
0.08% 109
2023
Q1
$304K Sell
3,309
-267
-7% -$23.3K 0.08% 112
2022
Q4
$324K Hold
3,576
0.08% 111
2022
Q3
$272K Hold
3,576
0.08% 112
2022
Q2
$302K Hold
3,576
0.09% 112
2022
Q1
$314K Hold
3,576
0.08% 118
2021
Q4
$313K Hold
3,576
0.08% 120
2021
Q3
$292K Hold
3,576
0.08% 121
2021
Q2
$326K Sell
3,576
-46
-1% -$4.1K 0.09% 116
2021
Q1
$310K Hold
3,622
0.09% 112
2020
Q4
$342K Hold
3,622
0.11% 110
2020
Q3
$315K Hold
3,622
0.12% 108
2020
Q2
$316K Buy
3,622
+50
+1% +$4.32K 0.13% 106
2020
Q1
$295K Sell
3,572
-50
-1% -$4.46K 0.14% 109
2019
Q4
$343K Sell
3,622
-266
-7% -$23.9K 0.11% 117
2019
Q3
$338K Sell
3,888
-1,700
-30% -$153K 0.13% 112
2019
Q2
$493K Sell
5,588
-648
-10% -$54.8K 0.18% 100
2019
Q1
$537K Hold
6,236
0.22% 100
2018
Q4
$480K Buy
+6,236
New +$485K 0.26% 79

Other funds holding NVS

Inlet Private Wealth's NVS Position: Q4 2024 in Review

Inlet Private Wealth sold out of Novartis (NVS) in Q4 2024, closing a stake of 2,229 shares — an estimated $256K sold.

Inlet Private Wealth first reported a position in NVS in Q4 2018 and held it in 23 quarters. The position peaked at $537K in Q1 2019. 1,340 funds tracked by Wall St. Rank hold NVS as of Q4 2024.

  • Inlet Private Wealth reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
  • Inlet Private Wealth sold 2,229 Novartis shares in Q4 2024, an estimated $256K.
  • Inlet Private Wealth first reported a position in Novartis in Q4 2018 and held it in 23 quarters.
  • Inlet Private Wealth's Novartis position peaked at $537K in Q1 2019.
  • 1,340 funds tracked by Wall St. Rank held Novartis as of Q4 2024.

Based on Inlet Private Wealth's 13F filing for Q4 2024, filed 24 Jan 2025.